Oppenheimer 26 th Annual Healthcare Conference Bill RutherfordChief Financial Officer and Executive Vice President Vic CampbellSenior Vice President Mark KimbroughVice President, Investor Relations

1 1 1 FORWARD-LOOKING STATEMENTS AND NON-GAAP FINANCIAL MEASURES This presentation may contain certain forward-looking statements provided by Company management. These statements are intended to be covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of Forward-looking statements include all statements that do not relate solely to historical or current facts, including statements regarding future operations, financial results, cash flows, costs and cost management initiatives, capital structure management, growth rates, and operational and strategic initiatives, and can also be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “intend,” “plan,” “initiative,” “continue” or words or phrases of similar meaning. These forward-looking statements speak only as of the date hereof and are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control. These risks and uncertainties are described in headings such as “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2014 and other reports filed with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ significantly from those expressed in any forward-looking statements in today’s presentation. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented and we do not intend to update any of these forward-looking statements. The presentation may contain certain non-GAAP measures, including Adjusted EBITDA. The Company’s earnings releases for the year ended December 31, 2014, and for the quarter and nine months ended September 30, 2015, located on the Company’s investor relations page at include reconciliations of certain non-GAAP financial measures and the most directly comparable financial measures calculated in accordance with GAAP. These non-GAAP financial measures should not be considered alternatives to the GAAP financial measures. References to “Company” used herein refer to HCA Holdings, Inc. and its affiliates, unless otherwise stated or indicated by context.

22 HCA has a diversified portfolio of assets strategically selected in attractive markets…… Denver Miami/Fort Lauderdale/WPB Dallas / Fort Worth San Antonio New Hampshire Western Idaho San Jose Southern California Las Vegas Idaho Falls Myrtle Beach Trident / Charleston Jacksonville North Central Florida Orlando Treasure Coast N-VA Richmond S-VA Augusta Tallahassee Wichita Oklahoma City Central Louisiana Lafayette New Orleans Panhandle El Paso Corpus Christi McAllen Brownsville Terre Haute Frankfort Chattanooga NWGA Atlanta Middle GA Anchorage Nashville Houston Tampa Austin Central London Gold labels indicate top 10 domestic markets by 3Q 2015 Adjusted EBITDA. HCA’s top ten markets generate approximately 63% of Adjusted EBITDA Salt Lake City Kansas City

3 3 3 Dallas Market 10 Acute Hospitals 1 Children’s Hospital 1 Behavioral Health Hospital ~3,000 Beds (Occupancy 71%) ~7,000 Physicians on Med Staff 5 Trauma Centers 12 Surgery Centers 31 Urgent Care Centers 6 Free Standing ERs

44 HCA’s Sustainable Growth Agenda “Be the Preferred Provider System in the Market” Industry leading quality and service Profitable growth through distinctive MD and patient relationships and value Efficiency levels that continue to lead the industry A well-informed response to evolving market environment Unparalleled development of future leaders

% Equivalent Admissions (1) 1.4% Revenue per Equivalent Admission (1) 7.9% Revenues 5.7% Adjusted EBITDA 9.5% Adjusted Net Income Attributable to HCA Holdings, Inc. (2) 15.1% Adjusted Diluted Earnings Per Share (2) (1)Same facility (2)Net income attributable to HCA Holdings, Inc. and diluted earning per share exclude losses (gains) on sales of facilities, losses on debt retirement, and legal claim costs. HCA Continues to Leverage Its Financial Strength (YTD 9/30/15 compared to prior year)

66 What Differentiates HCA Local Market Strategy & Execution Culture and Values Clinical Excellence Market Diversification Capital Deployment Size and Scale

Oppenheimer 26 th Annual Healthcare Conference Bill RutherfordChief Financial Officer and Executive Vice President Vic CampbellSenior Vice President Mark KimbroughVice President, Investor Relations